Facebook



Twitter

About Oncomet

Morphology to Molecular Oncopathology under one roof

 

India has an estimated 2.5 Million people living with Cancer with an annual occurrence estimation pegged at 7 Lakhs. The incidence of death because of cancer is around 5.5 Lakhs per year in India and among the top most all-cause mortality list.

A large number of cases aren’t detected or under-diagnosed because of less availability of proper infrastructure and lack of trained onco-pathologists. In order to ease the burden of cancer diagnosis in India, Metropolis brings forth a one of its kind revolutionary concept of conclusive cancer diagnosis.

Oncomet is a specialised division of Metropolis dedicated towards Cancer Diagnosis. In Onco-diagnosis single point, cost effective & quick diagnosis is a major void today. Oncomet with its comprehensive capabilities right from Morphology to Molecular Oncology helps bridge this void!

What do we offer?

Oncomet offers CONCLUSIVE diagnosis by correlating Flow Cytometry, IHC, Molecular & Genetic Final Reports with Morphology. Oncomet also has test panels that spans across Preventive, Diagnostic, Predictive, Prognostic & Theranostic Parameters. A fast turn around time with support from experts across the nation has earned us the trust of our oncologists, hospitals and patients.

Oncomet by Metropolis offers more than 500 tests, the largest test menu in India which is accredited by both NABL and CAP. See our test menu here.

 

Oncomet Logo FINAL with tagline

Are You A Doctor?